Crossmark

: Dr. Heuschmann reports grants from German Ministry of Research and Education, during the conduct of the study; research grants from German Ministry of Research and Education, European Union, Charité—Universitätsmedizin Berlin, Berlin Chamber of Physicians, German Parkinson Society, University Hospital Würzburg, Robert Koch Institute, German Heart Foundation, Federal Joint Committee (G-BA) within the Innovationfond, German Research Foundation, Bavarian State (ministry for science and the arts), German Cancer Aid, Charité—Universitätsmedizin Berlin (within Mondafis; supported by an unrestricted research grant to the Charité from Bayer), University Göttingen (within FIND-AF randomized; supported by an unrestricted research grant to the University Göttingen from Boehringer-Ingelheim), University Hospital Heidelberg (within RASUNOA-prime; supported by an unrestricted research grant to the University Hospital Heidelberg from Bayer, BMS, Boehringer-Ingelheim, Daiichi Sankyo), outside the submitted work. Dr. Bahmer reports grants from the German Center for Lung Research (DZL) and fees for lecturing, advice and travel expenses from AstraZeneca, GlaxoSmithKline. Novartis, Chiesi, Boehringer Ingelheim, MSD, Roche. Dr. Bellinghausen reports grants or contracts from Gilead Sciences. Dr. Hanses reports having received fees for presentations and lectures for DGINA, Akademie für Infektionsmedizin, and participation on the advisory boards for MSD, GSK and Sobi. Dr. Herold reports grants or contracts from the German Research Foundation (DFG), Ministry of Research and Education (BMBF), consulting fees from Janssen, Sanofi and AstraZeneca, participation on a data safety monitoring board or advisory Board for Atriva. Dr. Keil reports grants from European Union; German Research Foundation; German Federal Ministry of Research and Education; Innovationsfonds by the Federal Joint Committee (G-BA); and the Bavarian State Ministry of Health and Care. Dr. Pape reports having received support for attending ECCMID 2021 from Advanz Pharma Germany. Dr. Püntmann reports honoraria for presentations for Byer AG and Siemens AG, and being involved in the ACC Taskforce on long-term sequela of COVID-19 infection. Dr. Störk reports grants from Federal Ministry of Education and Research for the Comprehensive Heart Failure Center Würzburg. Dr. Nagel reports grants from Byer AG and NeoSoft Ltd., consulting fees from Bayer AG, honoraria for presentations for Byer AG, Pfizer AG and Siemens Healthineers. He has received payments for expert testimony by Bayer AG, participates in the Advisory board CMR-ICD: NCT04558723, has patents issued and received equipment from MEDIS and NeoSoft. Dr. Thibeault reports grants from the Deutsche Forschungsgemeinschaft. Dr. Witzenrath reports grants from Deutsche Forschungsgemeinschaft, Bundesministerium für Bildung und Forschung, Deutsche Gesellschaft für Pneumologie, European Respiratory Society, Marie Curie Foundation, Else Kröner Fresenius Stiftung, Capnetz Stiftung, International Max Planck Research School, Vaxxilon, Actelion, Bayer Health Care, Biotest, Boehringer Ingelheim. He received consulting fees from Noxxon, Pantherna, Vaxxilon, Aptarion, Glaxo Smith Kline, Sinoxa, Biotest, Thieme, and received honoraria for presentations from Astra Zeneca, Berlin Chemie, Chiesi, Novartis, Actelion, Boehringer Ingelheim, Glaxo Smith Kline, Biotest, Bayer Health Care. He has issued several patents. Dr. Vehreschild reports to have received honoraria for presentations from Merck / MSD, Gilead, Pfizer, Astellas Pharma, Basilea, German Centre for Infection Research (DZIF), University Hospital Freiburg/Congress and Communication, Academy for Infectious Medicine, University Manchester, German Society for Infectious Diseases (DGI), Ärztekammer Nordrhein, University Hospital Aachen, Back Bay Strategies, German Society for Internal Medicine (DGIM), Shionogi, Molecular Health, Netzwerk Universitätsmedizin, Janssen, NordForsk. He received research funding from Merck / MSD, Gilead, Pfizer, Astellas Pharma, Basilea, German Centre for Infection Research (DZIF), German Federal Ministry of Education and Research (BMBF), (PJ-T: DLR), University of Bristol, Rigshospitalet Copenhagen. All other authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this manuscript, except for the Network University Medicine.

: Informed consent was obtained from all individual participants included in the study.

: No identifying information is included in this article.

: NAPKON’s study protocols have been approved at institutional review boards/ethics committees of all participating study sites.

Document is current

Any future updates will be listed below